Cargando…
Identification, binding, and structural characterization of single domain anti-PD-L1 antibodies inhibitory of immune regulatory proteins PD-1 and CD80
Programmed death-ligand 1 (PD-L1) is a key immune regulatory protein that interacts with programmed cell death protein 1 (PD-1), leading to T-cell suppression. Whilst this interaction is key in self-tolerance, cancer cells evade the immune system by overexpressing PD-L1. Inhibition of the PD-1/PD-L1...
Autores principales: | Kang-Pettinger, Tara, Walker, Kayleigh, Brown, Richard, Cowan, Richard, Wright, Helena, Baravalle, Roberta, Waters, Lorna C., Muskett, Frederick W., Bowler, Matthew W., Sawmynaden, Kovilen, Coombs, Peter J., Carr, Mark D., Hall, Gareth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9811221/ https://www.ncbi.nlm.nih.gov/pubmed/36470427 http://dx.doi.org/10.1016/j.jbc.2022.102769 |
Ejemplares similares
-
Sequence-specific (1)H, (13)C and (15)N backbone NMR assignments for the N-terminal IgV-like domain (D1) and full extracellular region (D1D2) of PD-L1
por: Walker, Kayleigh, et al.
Publicado: (2022) -
Nanobody inhibitors of Plexin-B1 identify allostery in plexin–semaphorin interactions and signaling
por: Cowan, Richard, et al.
Publicado: (2023) -
Identification and characterisation of anti-IL-13 inhibitory single domain antibodies provides new insights into receptor selectivity and attractive opportunities for drug discovery
por: Walker, Kayleigh, et al.
Publicado: (2023) -
The CTLA‐4 immune checkpoint protein regulates PD‐L1:PD‐1 interaction via transendocytosis of its ligand CD80
por: Kennedy, Alan, et al.
Publicado: (2023) -
Co-crystallisation and humanisation of an anti-HER2 single-domain antibody as a theranostic tool
por: Sawmynaden, Kovilen, et al.
Publicado: (2023)